Table 2 Differences in the number of patients receiving allogeneic blood products, coagulation factors and resuscitation fluids (independent of amount) between the propensity score matched groups (LUKS: Cantonal Hospital Lucerne, USZ: University Hospital Zurich)

20 (11.6%)

51 (29.7%)

3.2 (1.8–5.7)

< 0.001

4 (2.3%)

9 (5.2%)

2.3 (0.7–7.7)

0.16

10 (5.8%)

6 (3.5%)

0.6 (0.2–1.6)

0.31

76 (44.2%)

66 (28.6%)

0.8 (0.5–1.2)

0.29

42 (24.4%)

59 (34.3%)

1.6 (1.0–2.6)

0.04

17 (9.9%)

41 (23.8%)

2.9 (1.5–5.3)

0.001

15 (8.7%)

6 (3.5%)

0.4 (0.1–1.0)

0.04

5 (2.9%)

37 (21.5%)

9.2 (3.5–23.9)

< 0.001

47 (27.3%)

27 (15.7%)

0.5 (0.3–0.8)

0.009